Thursday May 25th 2017

Posts Tagged ‘people’

Trainees in MS Research and Clinical Care Connect at the 2013 Tykeson Fellows Conference

Trainees in MS Research and Clinical Care Connect at the 2013 Tykeson Fellows Conference

The 4th Tykeson Fellows Conference on MS brought nearly 100 young National MS Society and MS International Federation research and clinical fellows together with senior scientists to learn about each other’s latest research efforts, as well as interact with the attendees [Read More]

Study Provides Strong Evidence for Benefits of Cognitive Rehabilitation to Improve Learning and Memory in People with MS

Study Provides Strong Evidence for Benefits of Cognitive Rehabilitation to Improve Learning and Memory in People with MS

Researchers at the Kessler Foundation in New Jersey report results of a clinical trial showing that a specific type of memory training improves learning in people with MS for at least 6 months after the training has ended, and also benefits other aspects of quality of life. [Read More]

Mixed Results from FDA Advisory Panel Meeting To Consider Marketing Approval of Lemtrada™ (alemtuzumab) for Relapsing MS

Mixed Results from FDA Advisory Panel Meeting To Consider Marketing Approval of Lemtrada™ (alemtuzumab) for Relapsing MS

An FDA advisory committee met to discuss the application for marketing approval of Lemtrada as a disease-modifying therapy for people with relapsing forms of MS. [Read More]

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]